These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16567593)

  • 1. Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis.
    Sugimoto K; Qi NR; Kazdová L; Pravenec M; Ogihara T; Kurtz TW
    Hypertension; 2006 May; 47(5):1003-9. PubMed ID: 16567593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-gamma dependent pathway.
    Sugimoto K; Kazdová L; Qi NR; Hyakukoku M; Kren V; Simáková M; Zídek V; Kurtz TW; Pravenec M
    J Hypertens; 2008 Jun; 26(6):1209-15. PubMed ID: 18475159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor blockers downsize adipocytes in spontaneously type 2 diabetic rats with visceral fat obesity.
    Mori Y; Itoh Y; Tajima N
    Am J Hypertens; 2007 Apr; 20(4):431-6. PubMed ID: 17386352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.
    Benson SC; Pershadsingh HA; Ho CI; Chittiboyina A; Desai P; Pravenec M; Qi N; Wang J; Avery MA; Kurtz TW
    Hypertension; 2004 May; 43(5):993-1002. PubMed ID: 15007034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation.
    Younis F; Stern N; Limor R; Oron Y; Zangen S; Rosenthal T
    Metabolism; 2010 Aug; 59(8):1200-9. PubMed ID: 20070992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization in high-fat-fed mice.
    Fujisaka S; Usui I; Kanatani Y; Ikutani M; Takasaki I; Tsuneyama K; Tabuchi Y; Bukhari A; Yamazaki Y; Suzuki H; Senda S; Aminuddin A; Nagai Y; Takatsu K; Kobayashi M; Tobe K
    Endocrinology; 2011 May; 152(5):1789-99. PubMed ID: 21427223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndrome.
    Khan AH; Imig JD
    Am J Hypertens; 2011 Jul; 24(7):816-21. PubMed ID: 21415842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of telmisartan and valsartan on insulin sensitivity in obese diabetic mice.
    Ushijima K; Takuma M; Ando H; Ishikawa-Kobayashi E; Nozawa M; Maekawa T; Shiga T; Fujimura A
    Eur J Pharmacol; 2013 Jan; 698(1-3):505-10. PubMed ID: 23195328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of telmisartan, valsartan and candesartan on mycophenolate mofetil pharmacokinetics in Japanese renal transplant recipients.
    Miura M; Satoh S; Kagaya H; Saito M; Inoue T; Ohkubo T; Habuchi T; Suzuki T
    J Clin Pharm Ther; 2009 Dec; 34(6):683-92. PubMed ID: 20175802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of effects of telmisartan and valsartan on late lumen loss and inflammatory markers after sirolimus-eluting stent implantation in hypertensive patients.
    Hong SJ; Shim WJ; Choi JI; Joo HJ; Shin SY; Park SM; Lim SY; Lim DS
    Am J Cardiol; 2007 Dec; 100(11):1625-9. PubMed ID: 18036359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine characterization and anorexigenic effects of telmisartan in diet- and glitazone-induced weight gain.
    Aubert G; Burnier M; Dulloo A; Perregaux C; Mazzolai L; Pralong F; Zanchi A
    Metabolism; 2010 Jan; 59(1):25-32. PubMed ID: 19793594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of telmisartan on the therapeutic efficacy of pitavastatin in high-fat diet induced dyslipidemic guinea pigs.
    Xu C; Fang D; Chen X; Xinyue L; Nie Y; Xie Y; Ma Y; Deng S; Zhang Z; Song X
    Eur J Pharmacol; 2015 Sep; 762():364-71. PubMed ID: 26057693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of telmisartan on forearm postischemic hyperemia and serum asymmetric dimethylarginine levels.
    Tomiyama H; Yamada J; Koji Y; Shiina K; Yoshida M; Yamashina A
    Am J Hypertens; 2007 Dec; 20(12):1305-11. PubMed ID: 18047921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telmisartan but not valsartan inhibits TGF-beta-mediated accumulation of extracellular matrix via activation of PPARgamma.
    Yao Y; Zou R; Liu X; Jiang J; Huang Q; He Y; Li M; Wang S; Zhou J; Ma D; Xu G
    J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):543-8. PubMed ID: 18846335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes.
    Qiang G; Zhang L; Yang X; Xuan Q; Shi L; Zhang H; Chen B; Li X; Zu M; Zhou D; Guo J; Yang H; Du G
    Eur J Pharmacol; 2012 Jun; 685(1-3):156-64. PubMed ID: 22546234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telmisartan, an angiotensin II type 1 receptor antagonist, attenuates T-type Ca2+ channel expression in neonatal rat cardiomyocytes.
    Morishima M; Wang Y; Akiyoshi Y; Miyamoto S; Ono K
    Eur J Pharmacol; 2009 May; 609(1-3):105-12. PubMed ID: 19292980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats.
    Harada N; Shimozawa N; Okajima K
    Transl Res; 2009 Sep; 154(3):142-52. PubMed ID: 19665690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effects of telmisartan and valsartan on human aortic vascular smooth muscle cell proliferation.
    Wang L; Zhao L; Zhang D; Chen JZ; Xue JL
    Chin Med J (Engl); 2012 Jun; 125(12):2200-4. PubMed ID: 22884153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internalization of constitutively active N111G MUTANT of AT1 receptor induced by angiotensin II-receptor antagonists candesartan, losartan, and telmisartan: comparison with valsartan.
    Bhuiyan MA; Hossain M; Nakamura T; Ozaki M; Nagatomo T
    J Pharmacol Sci; 2010; 112(4):459-62. PubMed ID: 20308802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)/Mas-dependent pathway.
    Schuchard J; Winkler M; Stölting I; Schuster F; Vogt FM; Barkhausen J; Thorns C; Santos RA; Bader M; Raasch W
    Br J Pharmacol; 2015 Aug; 172(15):3764-78. PubMed ID: 25906670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.